IGHE and allergic asthma: A new humanized monoclonal antibody FB825 against CepsilonX domain of the mIgE generated for the depletion of IgE producing B cells is currently evaluated in atopic dermatitis (NCT03758716) and allergic asthma (NCT05008965) without any published data, yet.